Cardiovascular risk and antiangiogenic therapy for age-related macular degeneration.
Tuñón, José
Cardiovascular risk and antiangiogenic therapy for age-related macular degeneration. [electronic resource] - Survey of ophthalmology - 339-48 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
0039-6257
10.1016/j.survophthal.2009.02.003 doi
Angiogenesis Inhibitors--adverse effects
Cardiovascular Diseases--chemically induced
Choroidal Neovascularization--drug therapy
Humans
Macular Degeneration--drug therapy
Risk Factors
Vascular Endothelial Growth Factor A--antagonists & inhibitors
Cardiovascular risk and antiangiogenic therapy for age-related macular degeneration. [electronic resource] - Survey of ophthalmology - 339-48 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
0039-6257
10.1016/j.survophthal.2009.02.003 doi
Angiogenesis Inhibitors--adverse effects
Cardiovascular Diseases--chemically induced
Choroidal Neovascularization--drug therapy
Humans
Macular Degeneration--drug therapy
Risk Factors
Vascular Endothelial Growth Factor A--antagonists & inhibitors